| 2022 | DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
| DIABETES & METABOLISM JOURNAL |
| 2020 | Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
| BIOMEDICINES |
| 2020 | Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in Vitro and in Vivo
| JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS |
| 2020 | Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules | DIABETES OBESITY & METABOLISM |
| 2019 | Reduced expression of pyruvate kinase in kidney proximal tubule cells is a potential mechanism of pravastatin altered glucose metabolism
| SCIENTIFIC REPORTS |
| 2017 | Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition | AUTOPHAGY |
| 2016 | A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes
| MEDICINE |
| 2016 | Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.
| PLOS ONE |
| 2016 | Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study
| Endocrinology and Metabolism (대한내분비학회지) |
| 2015 | Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes
| CARDIOVASCULAR DIABETOLOGY |
| 2015 | Risk of diabetes in patients treated with HMG-CoA reductase inhibitors | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2014 | The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
| DIABETES & METABOLISM JOURNAL |
| 2014 | HMG CoA Reductase Inhibitor Treatment Induces Dysglycemia in Renal Allograft Recipients | TRANSPLANTATION |
| 2013 | Discovery of DiPeptidyl Peptidase-4 Gene Variants and the Associations with Efficacy of Vildagliptin in Patients with Type 2 Diabetes - A Pilot Study
| JOURNAL OF DIABETES & METABOLISM |
| 2013 | Variants of the Adiponectin Gene and Diabetic Microvascular Complications in Patients with Type 2 Diabetes | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2012 | Dual pathways of p53 mediated glucolipotoxicity-induced apoptosis of rat cardiomyoblast cell: activation of p53 proapoptosis and inhibition of Nrf2-NQO1 antiapoptosis. | METABOLISM-CLINICAL AND EXPERIMENTAL |
